Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57K Sell
3,356
-660
-16% -$364 ﹤0.01% 9519
2026
Q1
$2.12K Buy
4,016
+1,825
+83% +$1.24K ﹤0.01% 9353
2025
Q4
$1.4K Buy
+2,191
New +$1.68K ﹤0.01% 9599
2025
Q3
Sell
-1,403
Closed -$1.53K 11040
2025
Q2
$1.53K Sell
1,403
-19,769
-93% -$27.4K ﹤0.01% 9601
2025
Q1
$23.5K Buy
+21,172
New +$22.4K ﹤0.01% 8119
2023
Q4
Sell
-70
Closed -$88 9975
2023
Q3
$88 Buy
+70
New +$102 ﹤0.01% 8917
2023
Q2
Sell
-953
Closed -$1.46K 9774
2023
Q1
$1.46K Sell
953
-7,095
-88% -$10.9K ﹤0.01% 8733
2022
Q4
$12.5K Buy
+8,048
New +$12.8K ﹤0.01% 8268
2022
Q3
Sell
-7,184
Closed -$13K 11022
2022
Q2
$13K Buy
+7,184
New +$15.7K ﹤0.01% 7560

Other funds holding ZTEK

UBS Group's ZTEK Position: Q2 2026 in Review

UBS Group reduced its Zentek (ZTEK) stake by 16% in Q2 2026, selling an estimated $364 and leaving 3,356 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #9519.

UBS Group first reported a position in ZTEK in Q2 2022 and has held it in 9 quarters since. The position peaked at $23.5K in Q1 2025. 30 funds tracked by Wall St. Rank hold ZTEK as of Q2 2026.

  • UBS Group held 3,356 shares of Zentek worth $1.57K as of Q2 2026.
  • UBS Group sold 660 Zentek shares in Q2 2026, an estimated $364.
  • Zentek made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9519 holding.
  • UBS Group first reported a position in Zentek in Q2 2022 and has held it in 9 quarters since.
  • UBS Group's Zentek position peaked at $23.5K in Q1 2025.
  • 30 funds tracked by Wall St. Rank held Zentek as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.